Hologic, Inc. (NASDAQ:HOLX) Q4 2024 Earnings Conference Call November 4, 2024 4:30 PM ET
Company Participants
Ryan Simon – Vice President, Investor Relations
Stephen MacMillan – Chairman, President & Chief Executive Officer
Essex Mitchell – Chief Operating Officer
Karleen Oberton – Chief Financial Officer
Conference Call Participants
Patrick Donnelly – Citi
Jack Meehan – Nephron Research
Anthony Petrone – Mizuho Group
Vijay Kumar – Evercore ISI
Casey Woodring – JPMorgan
Mike Matson – Needham & Company
Navann Ty – BNP Paribas
Ricardo Moreno – RBC Capital Markets
Maggie Wilmouth – William Blair
Andrew Cooper – Raymond James
Operator
Good afternoon, and welcome to the Hologic’s Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Shelly, and I am your operator for today’s call. Today’s conference is being recorded. All lines have been placed on mute.
I would now like to introduce Ryan Simon, Vice President, Investor Relations to begin the call.
Ryan Simon
Thank you, Shelly. Good afternoon and thank you for joining Hologic’s fourth quarter fiscal 2024 earnings call. With me today are Steve MacMillan, the company’s Chairman, President, and Chief Executive Officer; Essex Mitchell, our Chief Operating Officer; and Karleen Oberton, our Chief Financial Officer.
Our fourth quarter press release is available now on the Investors section of our website. We will also post our prepared remarks to our website shortly after we deliver them, and a replay of this call will be available on our website for the next 30 days.
Before we begin, we would like to inform you that certain statements we make today will be forward-looking. These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such factors include those referenced in the safe harbor statement included in our earnings release and SEC filings.
